NCT07286175
ClinicalTrials.gov
- Trial ID
- T-ctgov-NCT07286175
- Registry
- ClinicalTrials.gov
- NCT number
- NCT07286175
- Sponsor, as registered
- Eli Lilly and Company
- Phase
- PHASE2
- Indication
- Bipolar Disorder
- Status
- RECRUITING
- Start date
- 2025-11-24
- Primary completion
- 2027-11
- Registered countries
- Argentina, Brazil, China, India, Japan, Mexico, Puerto Rico, United States
- Sites
- 87
The sponsor's registered location list, which states intent rather than approval.
clinicaltrials.govctgov registryverified 2026-08-31
Notes on the record
Fields read from the ClinicalTrials.gov v2 API record. countries is the distinct country list across all registered locations; site_count is the number of location entries, which counts a country once per site, not once per country.
Company
Through brenipatide (LY3537031): Lilly
Cited in
Issues quoting NCT07286175 in their own text.